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Abstract
Objective: To determine the compliance with tuberculosis treatment among patients enrolled the tuberculosis 
control program in the city of Carapicuíba, Brazil, before and after the implementation of the directly observed 
treatment, short-course (DOTS) strategy. Methods: A retrospective historical cohort study of operational aspects 
based on records of attendance and treatment evolution of patients in self-administered treatment (SAT) and of 
those submitted to DOTS. Monthly treatment outcome tables were created, and the probability of compliance with 
the treatment was calculated for both groups of patients. Results: A total of 360 patients with tuberculosis met the 
inclusion criteria: 173 (48.1%) in the SAT group; and 187 (51.9%) in the DOTS group. Treatment compliance was 
6.1% higher in the DOTS group than in the SAT group. The proportion of patients completing the six months of 
treatment was 91.6% and 85.5% in the DOTS group and in the SAT group, respectively. Conclusions: The results 
of this study show that DOTS can be successfully implemented at primary health care clinics. In this population 
of patients, residents of a city with low incomes and a high burden of tuberculosis infection, DOTS was more 
effective than was SAT. 
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Resumo
Objetivo: Verificar a adesão ao tratamento dos casos atendidos no programa de controle da tuberculose do 
município de Carapicuíba (SP), antes e após a implantação da estratégia directly observed treatment, short-course 
(DOTS, tratamento supervisionado). Métodos: Estudo operacional do tipo coorte histórica a partir dos registros 
de comparecimento e evolução do tratamento dos pacientes submetidos ao tratamento autoadministrado (TAA) e 
daqueles submetidos a DOTS. Tábuas de desfecho de tratamento mês a mês foram elaboradas, e a probabilidade 
de adesão foi calculada para cada grupo de pacientes. Resultados: Um total de 360 pacientes com tuberculose 
preencheu os critérios de elegibilidade: 173 (48,1%) no grupo TAA e 187 (51,9%) no grupo TS. A adesão ao 
tratamento foi 6,1% maior no grupo DOTS do que no grupo TAA. Ao final de seis meses, 91,6% dos pacientes sob 
TS completaram o tratamento padrão, enquanto 85,5% dos pacientes do grupo TAA completaram o tratamento. 
Conclusões: Este estudo mostrou que a estratégia DOTS pode ser realizada com sucesso em unidades básicas de 
saúde e que essa estratégia foi mais efetiva que o TAA nesta população de pacientes de uma cidade com população 
de baixa renda e alta carga de tuberculose. 
Descritores: Tuberculose; Mycobacterium tuberculosis; Resultado de tratamento; Adesão ao medicamento.
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Carapicuíba, a bedroom community located 
in the greater metropolitan area of São Paulo, 
Brazil, is one of the most densely populated 
cities in the country (10,936 inhabitants/km2) 
and has been considered one of the priority 
cities since 1998 because it has one of the 
highest incidences of TB in the state of São 
Paulo (54.2/100,000 population infected; and 
32.3/100,000 population with active TB—data 
for 2005).
The DOTS strategy rests on five pillars: 
political commitment; detection of active 
cases; supervised drug administration; regular 
supply of first-line antituberculosis drugs; and 
the implementation of a case reporting and 
surveillance system.(7-9)
In 2008, approximately 40% of the TB 
patients in Brazil were treated under the DOTS 
strategy. However, there have been only a 
few studies assessing the results of the DOTS 
strategy in health care facilities and in municipal 
programs, and those have been uncontrolled.(8,9)
The objective of the present study was to 
determine the compliance with TB treatment 
among patients enrolled in the Programa de 
Controle da Tuberculose (PCT, Tuberculosis 
Control Program) in Carapicuíba, before and 
after the implementation of the DOTS strategy.
Methods
This was a retrospective historical cohort 
study of operational aspects involving TB patients 
enrolled in the Carapicuíba PCT, before and 
after the implementation of the DOTS strategy: 
those under self-administered treatment (SAT), 
between January 1 and December 31, 2003; and 
those treated under the DOTS strategy, between 
July 1, 2004 and June 30, 2005.
For the TB patients treated under the DOTS 
strategy, drug administration was directly 
observed at the referral health care clinic or at 
the health care clinic closest to their home, at a 
predetermined time of day, at least three times a 
week in the attack phase and twice a week in the 
maintenance phase, on weekdays. On weekends, 
the drug was self-administered. For housebound 
patients, drug administration was supervised in 
the home.
A TB case was defined as follows(10): an 
individual in whom the diagnosis of TB had 
been confirmed by sputum smear microscopy or 
culture; or an individual whose physician had 
Introduction
Tuberculosis (TB) remains a challenge and a 
major public health problem in the 21st century, 
although there are treatment regimens that 
have a greater than 95% efficacy in TB patients 
infected with Mycobacterium tuberculosis strains 
susceptible to first-line drugs. A large number 
of patients are noncompliant with treatment, 
especially in developing or underdeveloped 
countries, where the TB burden is much heavier, 
examples including Uganda (13.0%), Nigeria 
(10.0%), the Russian Federation (9.6%), South 
Africa (9.1%), and Brazil (8.3%).(1-3)
In an attempt to explain poor TB treatment 
compliance, many factors have been reported, 
such as the low level of investment in 
maintenance and in financing programs, as 
well as the low quality of health care services, 
the lack of motivation of professionals, TB/
HIV co-infection, the impoverishment of 
marginalized populations, and limited access to 
health care services on the part of certain groups 
considered vulnerable, such as the unemployed, 
the homeless, chronic alcoholics, and drug users, 
especially in large urban areas.(4,5)
In 2000, the World Health Organization set 
targets for the Millennium Development Goals 
and for the control of certain diseases, such as 
TB, creating the initiative known as Stop TB, 
which aims to halve the incidence of TB and 
the number of deaths from TB by 2015 in 
relation to 1990. Consolidated data for 2008 
provided by the Programa Nacional de Controle 
da Tuberculose (PNCT, Brazilian National 
Tuberculosis Control Program) showed that the 
incidence of TB infection was 37.1/100,000 
population and that the incidence of active TB 
was 20.6/100,000 population.(6,7)
In 2003, TB was listed as one of the public 
policy priorities in Brazil, and the need for 
detection of at least 70% of the active TB cases, 
as well as the increase of the cure rate to at 
least 85%, was agreed upon by municipal and 
state managers. In order to achieve this goal, 
the PNCT strengthened and decentralized 
the directly observed therapy, short-course 
(DOTS) strategy. Previously, on the basis of 
epidemiological criteria and operational data, 
the PNCT had classified 230 cities as priority 
cities, because the majority of the TB cases in 
Brazil were concentrated in those cities.(3,7,8)
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•	Discharge	due	to	death:	Patients	who	die	
during treatment will be removed from the 
rolls, regardless of the cause of death. 
•	Discharge	 due	 to	 unconfirmed	 transfer:	
Patients transferred to another health care 
facility will be discharged when there is no 
confirmation of their appearance at the 
other facility.
Because our groups were consecutive cohorts 
of patients enrolled in a local PCT, rather than 
a probability sample,(10) we used TB reporting 
forms and patient medical charts in order to 
compare the SAT and DOTS groups in terms 
of age, gender, level of education, occupation, 
HIV serology, localization of TB foci, sputum 
smear results (AFB detection), and history of 
TB treatment. The Epi Info 2000 statistical 
package, version 3.3, was used in order to 
create a database. We employed double data 
entry in order to check data consistency and 
eliminate typographical errors. To compare 
sociodemographic variables and clinical 
characteristics, we conducted bivariate analyses 
using the chi-square test or Fisher’s exact test 
and the same statistical package. The level of 
significance was set at p < 0.05.
In order to assess treatment compliance in 
the two groups (SAT and DOTS), we used the 
actuarial method, better known as the survival 
analysis technique or a survival table.(11) Survival 
(the dependent variable) was represented by 
treatment compliance, defined as the time 
elapsed between the inclusion of a TB case (date 
of initiation of the Brazilian National Ministry of 
Health-approved standard treatment regimen) 
and the occurrence of the event of interest 
(date of discharge after cure). In this technique, 
cases lost to follow-up, except for cases of 
noncompliance, are designated incomplete 
observations or censored cases (wx). This 
method calculates the probability of treatment 
compliance at pre-set intervals (monthly 
follow-up appointments), and the number of 
those at risk of noncompliance corresponds to 
the patients under treatment at the beginning 
of each x interval. The number of those at risk 
(lx) is adjusted for the number of censored cases 
occurring in the period, assuming that the 
censored cases occurred uniformly during the x 
period. Therefore, in the presence of censored 
cases, the number of patients under treatment 
and at risk of noncompliance at the beginning 
made a diagnosis of TB on the basis of clinical/
epidemiological data and complementary 
test results (e.g., X-ray, anatomopathological 
examination, determination of adenosine 
deaminase levels, etc.) and had prescribed one 
of the six-month treatment regimens that were 
standard at the time of data collection, either 
for new cases (treatment-naïve cases) or for 
retreatment after recurrence or noncompliance. 
An individual diagnosed with TB and meeting 
one of the following criteria was classified 
as a new TB case: having no history of TB 
treatment; having previously undergone TB 
treatment for less than 30 days; or having 
undergone TB treatment more than 5 years 
prior. Individuals who resumed treatment after 
being noncompliant with the basic regimen were 
classified as cases of retreatment, as were those 
who experienced recurrence after being treated 
and cured more than 5 years prior. Cases of 
tuberculous meningoencephalitis, drug-resistant 
TB, and multidrug-resistant TB were excluded 
from the study, as were confirmed cases of 
transfer and cases in residents of other cities.
We used the TB treatment outcome criteria 
established by the Brazilian National Ministry of 
Health(10): 
•	Discharge	after	cure:	Patients	who	initially	
tested positive for pulmonary TB will be 
discharged if, during treatment, they have 
two negative sputum smear microscopy 
results, one in the follow-up phase and 
one at the end of treatment. 
•	Discharge	 after	 treatment	 completion:	
Patients who were not submitted to 
sputum smear microscopy due to absence 
of expectoration will be discharged if 
the clinical data and complementary 
test results indicate that they are free of 
disease, as will those who initially tested 
negative for pulmonary TB and those with 
extrapulmonary TB. 
•	Discharge	due	to	noncompliance:	Patients	
who, after starting TB treatment, fail 
to appear for their scheduled follow-up 
appointments (for evaluation or for 
administration of the medication) for 
more than 30 consecutive days will be 
discharged. 
•	Discharge	due	to	a	change	in	the	diagnosis:	
Patients who were initially misdiagnosed 
will be discharged. 
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patients was 37.3 years (range, 4-84 years), and 
males predominated (at 60.6%). Regarding level 
of education, 27.1% had had 3 or fewer years of 
schooling and only 36.3% had had more than 
8 years of schooling. Regarding occupation, 
26.9% were homemakers or students, 45.3% 
were officially employed, and 27.8% were 
unofficially employed or were unemployed. Of 
the 237 subjects tested for HIV, 119 (50.2%) 
were in the SAT group and 118 (49.8%) were 
in the DOTS group. Of all subjects tested, 18 
(7.6%; 9 in each group) were HIV-positive.
Of the 360 patients studied, 301 (83.6%) 
had pulmonary TB, and 211 (70.1%) of those 
patients had active TB. Of the 59 patients 
diagnosed with extrapulmonary TB, 35 (59.3%) 
had pleural TB, 10 (16.9%) had peripheral lymph 
node TB, 3 (5.1%) had miliary TB, 2 (3.4%) had 
bone TB, and 9 (15.3%) had other forms of TB. 
Table 1 shows that there were no significant 
differences between the patients in the SAT 
group and those in the DOTS group in terms 
of sociodemographic variables, the variable “TB/
HIV coinfection”, or the variable “localization of 
TB foci”, as previously described. For the variable 
“history of TB treatment”, the SAT group had 
a higher proportion of retreatment cases than 
did the DOTS group, and this difference was 
significant.
Figures 1-4 were created on the basis of the 
information collected from the survival tables, 
with the conditional probabilities of compliance 
with the monthly treatment (intervals x1 to 
x6), in order to determine the percentage of 
discharges after cure among the TB patients 
enrolled in the Carapicuíba PCT, by treatment 
strategy (SAT or DOTS). Figure 1 shows that, at 
six months after treatment initiation, there was 
a significant difference in effectiveness between 
the SAT group and the DOTS group (6.09%). 
The probability of discharge after cure among 
the patients in the DOTS group was 91.61% 
(95% CI: 91.48-91.64), compared with 85.52% 
(95% CI: 85.30-85.73) among the patients in 
the SAT group. 
By stratifying the TB patients in the DOTS 
group and those in the SAT group by type of 
case (new or retreatment), localization of TB foci 
(pulmonary or extrapulmonary), and pulmonary 
TB (active or latent), we found that treatment 
compliance was also significantly higher among 
the patients in the DOTS group (Figures 2-4). 
of the x period is adjusted (l*x) by subtracting 
half of the censored cases from the total number 
of those at risk at the beginning of the period, 
assuming that the censored cases were, on 
average, at risk of noncompliance for only half 
of the follow-up period. In this technique, time 
is also divided into fixed (monthly) intervals, 
and the probability of treatment compliance 
(px) or noncompliance (qx) is calculated for each 
interval.(12,13) We therefore have the following:
(px =	1	−	qx), (qx = dx/l
*
x), and l
*
x = lx	−	(wx/2)
where
•	px is the conditional probability of 
treatment compliance in the x interval
•	qx is the conditional probability of 
treatment noncompliance in the x interval
•	l*x is the number of those at risk of 
noncompliance, in the x interval, corrected 
for the censored cases occurring in the x 
interval
•	lx is the number of patients at risk of 
noncompliance at the beginning of the 
period
•	dx is the number of patients who were 
noncompliant with the treatment
•	wx is the number of censored cases in the x 
interval
We calculated 95% CIs for the probabilities 
of treatment compliance in percentage on 
the basis of the survival tables, which are 
presented in the form of charts showing the 
conditional probabilities of compliance by x 
interval (monthly interval) up to the last month 
of follow-up (month 6), which resulted in the 
overall rate of treatment compliance (discharge 
after cure). The study protocol was approved by 
the Research Ethics Committee of the Federal 
University of São Paulo.
Results
A total of 360 patients met the inclusion 
criteria, of whom 173 (48.1%) were in the SAT 
group and 187 (51.9%) were in the DOTS group. 
Thirty-nine patients were excluded: 23 (59.0%) 
because they had been transferred to another 
facility (confirmed transfer); 9 (23.1%) because 
they were infected with single drug-resistant 
or multidrug-resistant M. tuberculosis strains; 
4 (10.2%) because they were residents of other 
cities; and 3 (7.7%) because they had tuberculous 
meningoencephalitis. The mean age of the 
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the patients with active TB, the cure rate was 
90.75% (95% CI: 90.64-90.80) for those in the 
DOTS group and 87.38% (95% CI: 85.51-87.24) 
for those in the SAT group (Figure 4a). Among 
the patients with latent TB, the cure rates were 
90.95% (95% CI: 90.56-91.02) and 79.06% 
(95% CI: 78.23-79.87), respectively (Figure 4b).
Discussion
Although compliance with TB treatment is 
difficult to predict, previously noncompliant 
patients and patients with alcohol, drug abuse, 
or mental health problems, as well as homeless 
individuals and HIV-positive patients, are usually 
noncompliant.(4,14-17) Incorrect or incomplete 
treatment is a cause of acquired resistance.(4,18)
The probability of cure of new TB cases was 
2% higher in the DOTS group than in the SAT 
group (95% CI: 91.94-92.19 vs. 89.47-89.59; 
Figure 2a). For the retreatment cases, the cure 
rate was 80.33% and 68.65% in the DOTS group 
and in the SAT group, respectively (95% CI: 
78.84-81.20 vs. 66.47-70.72; Figure 2b). In the 
DOTS group, treatment compliance among the 
patients with pulmonary TB was 91.13% (95% 
CI: 91.04-91.27), compared with 85.30% (95% 
CI: 85.15-85.44) in the SAT group (Figure 3a). 
The proportion of patients with extrapulmonary 
TB was 3.1% greater in the DOTS group than 
in the SAT group (Figure 3b), the respective 
cure rates being 90.09% (95% CI: 89.88-90.20) 
and 87.00% (95% CI: 86.73-87.26). Among 
Table 1 - General characteristics of the tuberculosis patients under self-administered treatment and those 
treated under the directly observed treatment, short-course strategy, Tuberculosis Control Program, Carapicuíba, 
Brazil, 2003-2005.
General characteristic SAT DOTS p
n % n %
Gender NS
Male 106 61.27 112 59.89
Female 67 38.73 75 40.11
Age, years NS
0-19 13 7.51 24 12.83
20-39 80 46.24 84 44.92
40-49 50 28.90 36 19.25
≥ 50 30 17.34 43 22.99
Educational level, yearsa NS
0-3 56 32.94 39 21.67
4-7 55 32.35 73 40.56
≥ 8 59 34.71 68 37.78
Occupationb NS
Homemaker/student 43 25.15 52 28.57
Officially employed 83 48.54 77 42.31
Unofficially employed/unemployed 45 26.32 53 29.12
HIV testing NS
Positive 9 5.2 9 4.81
Negative or not performed 164 94.8 178 95.19
Type of tuberculosis NS
Pulmonary 148 85.55 153 81.82
Extrapulmonary 25 14.45 34 18.18
Sputum smear microscopy NS
Positive 110 74.32 101 66.01
Negative or not performed 38 25.68 52 33.99
History of TB treatment 0.017
Yes 34 19.65 19 10.16
No 139 80.35 168 89.84
SAT: self-administered treatment; DOTS: directly observed treatment, short course; and NS: not significant. a10 cases lost 
to follow-up. b7 cases lost to follow-up.
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no significant decreases in the rates of incidence, 
mortality, noncompliance, or cure. In addition, 
in Brazil, there have been few studies like this 
one, involving the analysis of the effectiveness 
of DOTS under operational conditions.(8,11,14-19)
One of the limitations of this study was the 
comparison between the SAT group and the 
DOTS group. For ethical reasons, this comparison 
involved a historical series of patients treated in 
two different periods. However, the two groups 
were treated in consecutive years, which implies 
that were no significant changes in the major 
sociodemographic variables related to TB or in 
other important factors related to the various 
outcomes, except for the change in treatment 
strategy, from SAT to DOTS. The difference 
observed in the number of deaths, which was 
greater in the DOTS group, can be explained 
by the improved quality of the data in the case 
reporting and surveillance system databases. 
After the implementation of the DOTS strategy, 
it became possible to cross-reference the data 
in the Mortality Database with those in the 
São Paulo State Tuberculosis Patients Control 
System Database, which had not previously been 
a routine procedure.
Under operational conditions, the 
implementation of the DOTS strategy in 
Carapicuíba resulted in improved treatment 
compliance in comparison with SAT. These 
findings are consistent with those of studies 
conducted in the Brazilian cities of Rio de 
Janeiro, Ribeirão Preto, and Taboão da Serra, as 
well as with those of studies conducted in China.
(8,9,11,16) Our data showed that the probability of 
The World Health Organization recommends 
the use of the DOTS strategy for the treatment 
of TB, especially in developing countries.
(2,5,7,14) One of the major lines of research on 
TB is assessing the efficacy of the therapeutic 
interventions and the effectiveness of the 
DOTS strategy in selected, randomized groups 
of patients. Operational studies help to assess 
the acceptability and applicability of new or 
innovative treatment modalities in different 
settings and everyday situations in health 
care facilities and health programs. In Brazil, 
epidemiological and operational data related to 
TB indicate that, in recent years, there have been 
Figure 1 - Compliance with the six-month 
tuberculosis treatment, in percentage of cases, 
among the patients enrolled in the Tuberculosis 
Control Program, Carapicuíba, Brazil, 2003-2005, by 
treatment strategy. SAT: self-administered treatment; 
and DOTS: directly observed treatment, short-course.
Figure 2 - Compliance with the six-month tuberculosis treatment, in percentage of new cases (2a) and 
retreatment cases (2b), among the patients enrolled in the Tuberculosis Control Program, Carapicuíba, Brazil, 
2003-2005, by treatment strategy. SAT: self-administered treatment; and DOTS: directly observed treatment, 
short-course.
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16) Among the patients who reported a history of 
TB treatment, treatment compliance was better 
in the DOTS group than in the SAT group. In 
addition, the probability of discharge after 
cure was greater among the patients treated 
under the DOTS strategy, regardless of disease 
localization or sputum smear microscopy result.
Some studies have demonstrated that 
providing incentives to patients increases the 
rates of discharge after cure.(4,20-23) In the present 
study, the patients treated under the DOTS 
strategy were offered breakfast after each dose, 
as well as a monthly supply of nonperishable food 
items (a food basket) and public transportation 
passes. When necessary, the patients were 
discharge after cure/treatment completion was 
greater among the patients treated under the 
DOTS strategy than among those under SAT. 
At the end of the six-month treatment, the 
probability of discharge after cure/treatment 
completion was 91.6% among the patients 
treated under the DOTS strategy, compared 
with 85.5% among those under SAT. The results 
of this study show that the DOTS strategy can 
be successfully implemented at primary health 
care clinics, even in low-income populations 
residing in large urban areas with a high burden 
of tuberculosis infection, such as Carapicuíba 
and other PNCT priority cities in Brazil. Similar 
findings have been reported in other studies.(11,14-
Figure 3 - Compliance with the six-month tuberculosis treatment, in percentage of cases of pulmonary 
tuberculosis (3a) and extrapulmonary tuberculosis (3b), among the patients enrolled in the Tuberculosis Control 
Program, Carapicuíba, Brazil, 2003-2005, by treatment strategy. SAT: self-administered treatment; and DOTS: 
directly observed treatment, short-course.
Figure 4 - Compliance with the six-month tuberculosis treatment, in percentage of cases of active pulmonary 
tuberculosis (3a) and latent pulmonary tuberculosis (3b), among the patients enrolled in the Tuberculosis 
Control Program, Carapicuíba, Brazil, 2003-2005, by treatment strategy. SAT: self-administered treatment; and 
DOTS: directly observed treatment, short-course.
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offered amenities, such as drug administration 
at work or at home and extended hours at the 
health care clinics, in order to facilitate and 
individualize treatment, as has been done in 
other localities.(9,16-24)
The results of TB control programs are 
influenced by their managers and by the level 
of training/motivation of the health care 
professionals involved.(14,24-26) Greater treatment 
effectiveness and greater treatment compliance 
can be related to improvements in the 
relationships between patients/patient families 
and health care professionals.(13) The quality of 
the interaction between patients and health care 
professionals might be one of the main reasons 
for the excellent results of the DOTS strategy 
in different programs worldwide, including the 
PCT evaluated here.(10,11,14-17)
The relationship between directly observed 
treatment and cure rates is complex. In 
addition, the factors that might influence 
different outcomes are not totally predictable 
and cannot be objectively determined. However, 
direct observation of treatment is important 
for ensuring high rates of discharge after cure. 
In addition to directly observed treatment, 
systematic data monitoring and the political 
commitment to ensure prompt and appropriate 
access to diagnostic tests, with trained and 
motivated staff, are important measures, all of 
which are components of the DOTS strategy.(14,18)
Our results show that the DOTS strategy 
for TB control improved treatment compliance 
among the patients enrolled in the PCT under 
study, increasing the probability of cure after six 
months of standard treatment, under operational 
conditions.
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